JPS63239208A - Beauty or skin composition containing silymarine-rich extract of silybum marianum fruit and essential fatty acid - Google Patents
Beauty or skin composition containing silymarine-rich extract of silybum marianum fruit and essential fatty acidInfo
- Publication number
- JPS63239208A JPS63239208A JP63009436A JP943688A JPS63239208A JP S63239208 A JPS63239208 A JP S63239208A JP 63009436 A JP63009436 A JP 63009436A JP 943688 A JP943688 A JP 943688A JP S63239208 A JPS63239208 A JP S63239208A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- weight
- composition according
- evening primrose
- essential
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims description 55
- 235000004626 essential fatty acids Nutrition 0.000 title claims description 20
- 239000000284 extract Substances 0.000 title claims description 14
- 235000010841 Silybum marianum Nutrition 0.000 title claims description 8
- 235000013399 edible fruits Nutrition 0.000 title claims description 6
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 title claims description 4
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 title claims description 4
- 244000272459 Silybum marianum Species 0.000 title claims 2
- 230000003796 beauty Effects 0.000 title 1
- 239000003921 oil Substances 0.000 claims description 29
- 235000019198 oils Nutrition 0.000 claims description 29
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 19
- 150000003254 radicals Chemical class 0.000 claims description 18
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 claims description 17
- 235000020664 gamma-linolenic acid Nutrition 0.000 claims description 17
- 229960002733 gamolenic acid Drugs 0.000 claims description 17
- 241000219925 Oenothera Species 0.000 claims description 15
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 15
- 229910052783 alkali metal Inorganic materials 0.000 claims description 13
- -1 alkali metal salt Chemical class 0.000 claims description 13
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 12
- 150000003863 ammonium salts Chemical group 0.000 claims description 12
- 229940087168 alpha tocopherol Drugs 0.000 claims description 11
- 229960000984 tocofersolan Drugs 0.000 claims description 11
- 150000003626 triacylglycerols Chemical class 0.000 claims description 11
- 239000002076 α-tocopherol Substances 0.000 claims description 11
- 235000004835 α-tocopherol Nutrition 0.000 claims description 11
- 239000002253 acid Substances 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- 238000007127 saponification reaction Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- 239000000499 gel Substances 0.000 claims description 7
- 241000320380 Silybum Species 0.000 claims description 6
- 235000008524 evening primrose extract Nutrition 0.000 claims description 6
- 239000010475 evening primrose oil Substances 0.000 claims description 6
- 229940089020 evening primrose oil Drugs 0.000 claims description 6
- 229930003935 flavonoid Natural products 0.000 claims description 6
- 150000002215 flavonoids Chemical class 0.000 claims description 6
- 235000017173 flavonoids Nutrition 0.000 claims description 6
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 6
- 235000007586 terpenes Nutrition 0.000 claims description 6
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 6
- 239000000341 volatile oil Substances 0.000 claims description 6
- 241000196324 Embryophyta Species 0.000 claims description 5
- 239000002202 Polyethylene glycol Substances 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 5
- 229920001223 polyethylene glycol Polymers 0.000 claims description 5
- 150000003505 terpenes Chemical class 0.000 claims description 5
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 5
- 239000008158 vegetable oil Substances 0.000 claims description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 4
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 4
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 4
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 4
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 4
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 4
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 4
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 4
- 240000000171 Crataegus monogyna Species 0.000 claims description 4
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 4
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 4
- 240000001890 Ribes hudsonianum Species 0.000 claims description 4
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 4
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 4
- 150000001340 alkali metals Chemical class 0.000 claims description 4
- 235000021324 borage oil Nutrition 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000006210 lotion Substances 0.000 claims description 4
- 239000002994 raw material Substances 0.000 claims description 4
- 238000012216 screening Methods 0.000 claims description 4
- 235000008694 Humulus lupulus Nutrition 0.000 claims description 3
- 235000019486 Sunflower oil Nutrition 0.000 claims description 3
- 235000005687 corn oil Nutrition 0.000 claims description 3
- 239000002285 corn oil Substances 0.000 claims description 3
- 239000002600 sunflower oil Substances 0.000 claims description 3
- 241000208140 Acer Species 0.000 claims description 2
- 241000233866 Fungi Species 0.000 claims description 2
- 239000008168 almond oil Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 229940096421 milk thistle extract Drugs 0.000 claims description 2
- 235000020727 milk thistle extract Nutrition 0.000 claims description 2
- 239000004006 olive oil Substances 0.000 claims description 2
- 235000008390 olive oil Nutrition 0.000 claims description 2
- 239000010497 wheat germ oil Substances 0.000 claims description 2
- 239000002075 main ingredient Substances 0.000 claims 3
- 239000010773 plant oil Substances 0.000 claims 2
- 150000004671 saturated fatty acids Chemical class 0.000 claims 2
- 244000144725 Amygdalus communis Species 0.000 claims 1
- 235000011437 Amygdalus communis Nutrition 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 229920005862 polyol Polymers 0.000 claims 1
- 150000003077 polyols Chemical class 0.000 claims 1
- 235000003441 saturated fatty acids Nutrition 0.000 claims 1
- 210000000952 spleen Anatomy 0.000 claims 1
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 14
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- 239000003755 preservative agent Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000002335 preservative effect Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 235000014113 dietary fatty acids Nutrition 0.000 description 7
- 239000000194 fatty acid Substances 0.000 description 7
- 229930195729 fatty acid Natural products 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 7
- 229920002125 Sokalan® Polymers 0.000 description 6
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 6
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229920002674 hyaluronan Polymers 0.000 description 5
- 229960003160 hyaluronic acid Drugs 0.000 description 5
- 229960004488 linolenic acid Drugs 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 239000004166 Lanolin Substances 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 3
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 229960000541 cetyl alcohol Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- BMGOAOMKRNIFAM-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-2-oxoacetic acid Chemical compound COC1=CC=C(C(=O)C(O)=O)C=C1OC BMGOAOMKRNIFAM-UHFFFAOYSA-N 0.000 description 2
- 229940123457 Free radical scavenger Drugs 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 2
- 241001135917 Vitellaria paradoxa Species 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229940107126 milk thistle fruit Drugs 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical class CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 229940100460 peg-100 stearate Drugs 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 239000002516 radical scavenger Substances 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- 229940057910 shea butter Drugs 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 235000017700 silymarin Nutrition 0.000 description 2
- 229960004245 silymarin Drugs 0.000 description 2
- 239000002884 skin cream Substances 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 125000005457 triglyceride group Chemical group 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- HOBAELRKJCKHQD-UHFFFAOYSA-N (8Z,11Z,14Z)-8,11,14-eicosatrienoic acid Natural products CCCCCC=CCC=CCC=CCCCCCCC(O)=O HOBAELRKJCKHQD-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- LKZMHCTVMRFUGC-UHFFFAOYSA-N 2-oxopyrrolidine-1,3-dicarboxylic acid Chemical compound OC(=O)C1CCN(C(O)=O)C1=O LKZMHCTVMRFUGC-UHFFFAOYSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 235000021298 Dihomo-γ-linolenic acid Nutrition 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241000219929 Onagraceae Species 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000011102 Thera Species 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000010473 blackcurrant seed oil Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 230000032677 cell aging Effects 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000003869 coulometry Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- HOBAELRKJCKHQD-QNEBEIHSSA-N dihomo-γ-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCCCC(O)=O HOBAELRKJCKHQD-QNEBEIHSSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000008481 normal tissue growth Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 210000004923 pancreatic tissue Anatomy 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920002189 poly(glycerol 1-O-monomethacrylate) polymer Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229940072033 potash Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229950003429 sorbitan palmitate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229940034252 thymus extracts Drugs 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 229940045860 white wax Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
産業上の利用分野
本発明は、シリマリンが豊富に含まれるオオアザミの果
実の抽出物と不可欠脂肪酸とを含む美容用または皮膚用
の新規な組成物に関するものである。DETAILED DESCRIPTION OF THE INVENTION Field of the Invention The present invention relates to a novel cosmetic or dermatological composition comprising an extract of milk thistle fruit rich in silymarin and essential fatty acids.
従来の技術
「サンザシのアブソリニート」と呼ばれるオオアザミの
抽出物は遊離基が形成されるのを阻止する物質である。Prior Art Milk thistle extract, called "hawthorn absolinate", is a substance that inhibits the formation of free radicals.
遊離基とは「孤立した」電子を一時的に捕獲した原子ま
たは分子である。反対向きのスピンと対を形成していな
いこの不対電子があるために遊離基の反応性が極めて大
きくなる。すなわち、遊離基は周囲の分子との反応性が
大きいため、今度はこれら周囲の分子が遊離基になる。A free radical is an atom or molecule that has temporarily captured a "lone" electron. This unpaired electron, which is not paired with an opposite spin, makes the free radical extremely reactive. That is, since free radicals are highly reactive with surrounding molecules, these surrounding molecules in turn become free radicals.
この機構によるとこれら「励起分子」の非常に大きな毒
性を説明することができる。つまり、遊離基は、細胞の
主要構成要素である核、蛋白質、細胞膜を攻撃する。こ
の中でも特に細胞膜が攻撃される。This mechanism can explain the enormous toxicity of these "excited molecules." In other words, free radicals attack the main components of cells: the nucleus, proteins, and cell membranes. Among these, cell membranes are particularly attacked.
ところで、細胞膜のリン脂質の構成成分である不可欠脂
肪酸は特に二重結合の部分が遊離基に弱い。Incidentally, essential fatty acids, which are constituents of phospholipids in cell membranes, are particularly vulnerable to free radicals at their double bonds.
発明が解決しようとする課題
炭素−炭素の二重結合は、細胞膜の構造と硬度を堡証し
ている。遊離基が存在していると膜は亀裂が入ったり曲
がったりして弱くなるだけでなく流動性が低下し、イオ
ンの運動の制御能力が落ちる。Problems to be Solved by the Invention Carbon-carbon double bonds are evidence of the structure and hardness of cell membranes. The presence of free radicals not only weakens the membrane by cracking and bending it, but also reduces its fluidity, reducing its ability to control the movement of ions.
このように膜が変化すると細胞の新陳代謝が影、響を受
ける。細胞に対する保護が弱くなり、酸素供給が減少し
、栄養がゆきわたりにくくなるため、細胞は少しずつ増
殖機能を失い、硬化し、次いで死に至る。このように、
遊離基とその結果発生する過酸化過程は、細胞の老化、
従って皮膚の老化に重要な役割を演する。Changes in the membrane like this affect the metabolism of the cell. As protection for cells weakens, oxygen supply decreases, and nutrients become less available, cells gradually lose their ability to proliferate, harden, and then die. in this way,
Free radicals and the resulting peroxidation process contribute to cellular aging,
Therefore, it plays an important role in skin aging.
このため、遊離基の極めて有効な捕獲剤であり老化防止
機能をもつ「サンザシのアブソリニート」と呼ばれる美
容用または皮膚用の組成物と回復機能をもつ不可欠脂肪
酸を組み合せることは非常に重要である。For this reason, it is of great importance to combine cosmetic or dermatological compositions called ``hawthorn absolinate'', which are highly effective scavengers of free radicals and have anti-aging properties, with essential fatty acids that have restorative properties. .
課題を解決するための手段
そこで、本発明によれば、肌の手入れのための美容用ま
たは皮膚用組成物であって、主要成分として、
A)シリマリンが豊富に含まれるオオアザミの果実の抽
出物である「サンデシのアブソI75−ト」と呼ばれる
物質と、
B)下記のいずれかの形態、すなわち
−遊離基の形態(1)、
−アルカリ金属塩またはアンモニウム塩の形態(2)、
−トリグリセリドの形態(3)、または、上記3つの形
態(1)、(2)、(3)のうちの2つの混合物、また
は、これ
ら3つの形態すべての混合物の形態
の形態に限られ、炭素原子を18〜22個含む1種また
は複数の不可欠ポリ不飽和脂肪酸と
の混合物を含むことを特徴とする組成物が提供される。Means for Solving the Problems Therefore, according to the present invention, there is provided a cosmetic or dermatological composition for skin care, which comprises as a main component: A) an extract of milk thistle fruit rich in silymarin; B) in any of the following forms, namely: - in the form of free radicals (1), - in the form of alkali metal or ammonium salts (2), - in the form of triglycerides; Form (3), or a mixture of two of the above three forms (1), (2), and (3), or a mixture of all three forms, with 18 carbon atoms Compositions are provided that are characterized in that they contain a mixture of one or more essential polyunsaturated fatty acids comprising ˜22 essential polyunsaturated fatty acids.
本発明は特に、上記成分B)が、遊離基の形態(1)と
、トリグリセリドの形態(3)と、トリグリセリド(3
)の全部または一部を鹸化して得られたアルカリ金属塩
またはアンモニウム塩の形態(2)で同時に存在し、炭
素原子を18〜22個含む不可欠ポリ不飽和脂肪酸で構
成されていることを特徴とする組成物に関す−0
さらに、本発明の組成物の成分A)に遊離基捕獲剤と呼
ばれる他の物質を添加して「サンザシのアブソ’J s
−) Jの作用を補強することは極めて妥当である。The invention particularly provides that component B) is present in the free radical form (1), in the triglyceride form (3), and in the triglyceride form (3).
) is simultaneously present in the form (2) of an alkali metal salt or ammonium salt obtained by saponifying all or part of In addition, other substances called free radical scavengers are added to component A) of the composition of the present invention to produce the composition "Hawthorn Abso'J s
-) It is extremely reasonable to reinforce the effect of J.
この場合に添加される物質としては、例えばオレフィン
系、アクリル系、環式の精油のテルペン、そのアルコー
ル誘導体、フラボノイドが挙げられる。分子構造を見る
とこれら化合物に遊離基捕獲剤としての機能があること
がわかる。Examples of substances added in this case include olefinic, acrylic, and cyclic terpenes of essential oils, alcohol derivatives thereof, and flavonoids. Looking at the molecular structure, it can be seen that these compounds function as free radical scavengers.
さらに、抗酸化機能と抗遊離基機能が様々な文献に記載
されている例えばビタミンE1すなわちα−トコフェロ
ール、ビタミンC1ビタミンA1およびこれらビタミン
の誘導体を添加してもよい。Furthermore, it is possible to add, for example, vitamin E1 or alpha-tocopherol, vitamin C1, vitamin A1 and derivatives of these vitamins, whose antioxidant and anti-free radical functions have been described in various documents.
このようなわけで本発明は、特に成分A)が、精油のテ
ルペンと、フラボノイドと、α−トコフェロールとをさ
らに含むことを特徴とする組成物に関する。The invention therefore particularly relates to a composition characterized in that component A) further comprises essential oil terpenes, flavonoids and alpha-tocopherol.
本発明によればさらに、主要成分として、−オオアザミ
の抽出物10〜30重量%と、−精油のテルペン5〜1
5重量%と、
−フラボノイド5〜15重量%と、
−α−トコフェロール5〜20重量%と、−不可欠脂肪
酸のトリグリセリド(3)25〜40重量%と、
−遊離基の形態、好ましくはγ−リノレン酸の形態の不
可欠脂肪酸(1)と、例えばトリグリセリド(3)の全
部または一部の鹸化により得ることのできるアルカリ金
属塩またはアンモニウム塩の形態の不可欠脂肪酸(2N
O〜25重量%とが含まれる混合物0.5〜10重量%
を含むことを特徴とする組成物が提供される。According to the invention, the main components further include: - 10 to 30% by weight of extract of milk thistle; - 5 to 1% of terpenes of essential oil;
- 5-15% by weight of flavonoids; - 5-20% by weight of α-tocopherol; - 25-40% by weight of triglycerides of essential fatty acids (3); - in free radical form, preferably γ- Essential fatty acids in the form of linolenic acid (1) and essential fatty acids in the form of alkali metal or ammonium salts (2N
0.5-10% by weight of a mixture containing O-25% by weight
A composition comprising:
上記の混合物がルリジシャ油を25〜40%含んだもの
は、スキナヘンジャ−(SKINAVENGER)
という名称で商標登録されている。The above mixture containing 25 to 40% borage oil is SKINAVENGER.
The name is registered as a trademark.
上記の組成物では、アルカリ金属塩またはアンモニウム
塩の形態のγ−リノレン酸はマツヨイグサ属植物の油の
鹸化により得ることが好ましい。In the above composition, γ-linolenic acid in the form of an alkali metal salt or an ammonium salt is preferably obtained by saponification of the oil of a plant of the genus evening primrose.
本発明はさらに、主要成分として、
− マツヨイグサ属植物の油1〜10重量%と、−・オ
オアザミの脱脂果実(の乾燥抽出物)5%と、
・ポリエチレングリコール中に含まれたα−トコフェロ
ール0.05〜2重量%と
の混合物1〜10重量%と
が含まれる混合物を含むことを特徴とする組成物に関す
る。The present invention further provides the following main components: - 1 to 10% by weight of oil of a plant of the genus Evening Primrose; - 5% (dry extract of) the defatted fruit of milk thistle; - 0 α-tocopherol contained in polyethylene glycol. .05 to 2% by weight; and 1 to 10% by weight.
特に、本発明は、主要成分として、
− マツヨイグサ属植物の油5重量%と、−・オオアザ
ミの脱脂果実(の乾燥抽出物) 5%と、
・ポリエチレングリコール中に含まれたα−トコフェロ
ール1重量%と
の混合物5重量%と、
−UVA−UVB用紫外線遮蔽剤1〜10重量%と、
−膵臓の抽出物1〜10重景%重
量含まれる混合物を含むことを特徴とする組成物に関す
る。In particular, the present invention provides as main components - 5% by weight of oil of a plant of the genus Evening Primrose; - 5% (dry extract of) defatted fruit of milk thistle; - 1% by weight of α-tocopherol contained in polyethylene glycol. - 1 to 10% by weight of an ultraviolet screening agent for UVA-UVB; - 1 to 10% by weight of an extract of pancreas.
シルブム・マリアヌムの脱脂果実の乾燥抽出物5%とポ
リエチレングリコール中に含まれたα−トコフェロール
1重量%とで構成される混合物は、フラボフェロール(
FLAVOP)IBROL)という名称で商標登録され
ている。A mixture consisting of 5% dry extract of defatted fruit of Sylvum marianum and 1% by weight of α-tocopherol in polyethylene glycol contains flavopherols (
The trademark is registered under the name FLAVOP)IBROL).
上記の組成物は、油相に可溶性のある所定の物質と水相
に可溶性のある他の物質を成分A)中でも成分B)中で
も同じぐらいよく混合することができるという利点を有
する。The above compositions have the advantage that certain substances soluble in the oil phase and other substances soluble in the aqueous phase can be mixed equally well in component A) and in component B).
例えば、「サンザシのアブソリュート」は水溶性であり
、精油のテルペン、フラボノイド、α−トコフェロール
は油溶性である。同様に、不可欠脂肪酸のトリグリセリ
ドは油溶性であるが、遊離状態の、または塩の形態の不
可欠脂肪酸は水溶性である。For example, "hawthorn absolute" is water-soluble, and essential oils such as terpenes, flavonoids, and alpha-tocopherol are oil-soluble. Similarly, triglycerides of essential fatty acids are oil-soluble, whereas essential fatty acids in free or salt form are water-soluble.
上記成分B)中の不可欠脂肪酸のトリグリセリドは合成
による一般的なトリグリセリドである。The essential fatty acid triglycerides in component B) above are synthetic, common triglycerides.
このようなトリグリセリドはこのトリグリセリドを天然
状態で含んでいる1種または複数の原料から得ることも
できる。このような原料は主に植物油である。Such triglycerides can also be obtained from one or more sources that naturally contain the triglycerides. Such raw materials are primarily vegetable oils.
例としては、小麦胚芽油、オリーブ油、コーン油、ヒマ
ワリ油、せアーモンド油、マツヨイクサ属植物の油、オ
ニジシャ油、黒スグリの種子の油を挙げることができる
。これら油はいずれも1種または複数の不可欠脂肪酸を
様々な割合で含んでいる。By way of example, mention may be made of wheat germ oil, olive oil, corn oil, sunflower oil, almond oil, oil of evening primroses, oil of the genus Oenothera, oil of black currant seeds. All of these oils contain varying proportions of one or more essential fatty acids.
トリグリセリドの鹸化は通常の方法で行う。このだめに
は、特に、アルカリ金属の水酸化物(ソーダまたはカリ
)を用いる。Saponification of triglycerides is carried out in a conventional manner. In particular, alkali metal hydroxides (soda or potash) are used in this reservoir.
この鹸化処理は、ポリ不飽和脂肪酸が極めて酸化しやす
いことを考えて酸化防止剤の存在下で実施する。This saponification treatment is carried out in the presence of an antioxidant, considering that polyunsaturated fatty acids are extremely susceptible to oxidation.
上記成分B)中にアルカリ金属塩の形態で存在している
ポリ不飽和脂肪酸は、ナトリウム塩またはカリウム塩で
あることが好ましい。The polyunsaturated fatty acids present in the form of alkali metal salts in component B) are preferably sodium or potassium salts.
不可欠ポリ不飽和脂肪酸には2種類ある。1つはγ−リ
ノレン酸であり、もう1つはリルン酸である。There are two types of essential polyunsaturated fatty acids. One is γ-linolenic acid and the other is linuric acid.
皮膚に最も豊富に存在している不可欠脂肪酸は、新陳代
謝により以下のように変換されるリルン酸を先駆物質と
して含んでいる。The most abundant essential fatty acids in the skin include lylunic acid as a precursor, which is converted metabolically as follows.
C18:2 → C18:3 →リルン
酸 γ−リノレン
酸→ C20: 3 → C20:4ジ
ホモγ−リノレン酸 アラキド
ン酸これらすべての酸は組織が正常に成長し生理的活動
を行うために不可欠である。C18:2 → C18:3 → Lilunic acid γ-linolenic acid → C20: 3 → C20:4 Dihomoγ-linolenic acid Arachidonic acid All these acids are essential for normal tissue growth and physiological activities. .
上記のトリグリセリドの形態の不可欠脂肪酸を豊富に含
む油としては、ヒマワリ油(リルン酸57%)、コーン
油(リルン酸40%)、マツヨイグサ属植物の油(リル
ン酸71%とγ−リノレン酸9%)、ルリジシャ油、黒
スグリの種子の油が挙げられる。Oils rich in the essential fatty acids in the form of triglycerides listed above include sunflower oil (57% lylunic acid), corn oil (40% lylunic acid), evening primrose oil (71% lylunic acid and 9% gamma-linolenic acid). %), borage oil, and black currant seed oil.
人間の場合には、リルン酸からγ−リノレン酸への変換
には大きな制約があり、この変換が不可能になってしま
う外的要因が多数ある。特に、この変換は老化するにつ
れ不十分にしか行われなくなる。In humans, there are significant restrictions on the conversion of linolenic acid to γ-linolenic acid, and there are many external factors that make this conversion impossible. In particular, this conversion becomes less efficient as we age.
、上記の不可欠脂肪酸の中ではr−リノレン酸が特に重
要である。Among the essential fatty acids mentioned above, r-linolenic acid is particularly important.
本発明によれば、特に、上記成分B)が、遊離基の形態
のγ−リノレン酸(1)と、γ−リノレン酸が豊富に含
まれる原料から得られた油(3)と、この油(3)の鹸
化により得られたr−リノレン酸のアルカリ金属塩また
はアンモニウム塩(2)とからなる混合物であることを
特徴とする組成物が提供される。According to the invention, in particular component B) comprises γ-linolenic acid (1) in free radical form and an oil (3) obtained from a raw material rich in γ-linolenic acid; There is provided a composition characterized in that it is a mixture consisting of the alkali metal salt or ammonium salt (2) of r-linolenic acid obtained by saponification of (3).
マツヨイグサ属植物であるメマツヨイグサ([1eno
thera Bienis)またはオオマツヨイグサ(
Oenothera Bienis Lamarkia
na)の種子から抽出された油、ルリジシャ油、黒スグ
リの種子の油は、γ−リノレン酸を豊富に含む3つの重
要な植物油である。Evening primrose ([1eno
thera Bienis) or evening primrose (
Oenothera Bienis Lamarkia
Oil extracted from seeds of Na), borage oil, and oil of black currant seeds are three important vegetable oils rich in γ-linolenic acid.
本発明の組成物で使用可能なr −IJルン酸を含む油
としては、シフォミケス類スピルリン目の菌、カエデの
種子、またはホップを抽出して得られた油をさらに挙げ
ることができる。Oils containing r -IJ phosphoric acid that can be used in the compositions of the present invention can further include oils obtained by extracting fungi of the order Siphomycetes, maple seeds, or hops.
もちろん、γ−リノレン酸を含む天然の原料から抽出し
た他の油もすべて用いることができる。Of course, all other oils extracted from natural sources containing gamma-linolenic acid can also be used.
本発明は、特に、上記成分B)が、遊離基の形dのγ−
リノレン酸(1)と、マツヨイグサ属植物(7)油(3
)と、マツヨイグサ属植物の油(3)の鹸化により得ら
れたr−リノレン酸のアルカリ金属塩(2)とからなる
混合物であることを特徴とする組成物に関する。The invention particularly provides that component B) is γ-
Linolenic acid (1) and evening primrose (7) oil (3)
) and an alkali metal salt of r-linolenic acid (2) obtained by saponification of oil (3) of a plant belonging to the genus Evening Primrose.
本発明の組成物には皮膚に対して有効な公知のあらゆる
物質が含まれていてもよい。そのような物質としては、
コラーゲン、エラスチン、ヒアルロン酸や、湿潤剤であ
る例えば尿素、カルボキシピロリドン酸とその塩のほか
、ビタミン抽出物、香料、保存剤、着色料、膵臓または
胸腺の抽出物、ホホバ油、シアバター、γ−オリザノー
ルが挙げられる。The compositions of the invention may contain any known skin-effective substances. Such a substance is
Collagen, elastin, hyaluronic acid and humectants such as urea, carboxypyrrolidonic acid and its salts, as well as vitamin extracts, fragrances, preservatives, colorants, pancreatic or thymus extracts, jojoba oil, shea butter, gamma - oryzanol.
皮膚に遊離基が形成されるときにはUV放射線が重要な
役割を果たすため、上記の組成物にはさらに少量の紫外
線のフィルタまたは遮蔽剤が含まれていてもよい。例え
ばUVAとUVB放射線のフィルタとしては、2−ヒド
ロキシ−4−メトキシプンゾフェン、ナトリウム塩の形
態の3,4−ジメトキシフェニルグリオキシル酸を挙げ
ることができる。Since UV radiation plays an important role in the formation of free radicals in the skin, the above compositions may also contain small amounts of UV filters or screening agents. For example, as a filter for UVA and UVB radiation, mention may be made of 2-hydroxy-4-methoxypunzophene, 3,4-dimethoxyphenylglyoxylic acid in the form of its sodium salt.
本発明の組成物は、美容術で用いられるあらゆる形態で
提供することができる。例えばクリームまたはゲルであ
ればビンやチューブに入れ、乳剤またはローションであ
ればガラスまたはプラスチックの小ビンや、液量計付小
ビン、つまり液滴の数を数えることのできる器具を備え
た小ビン、さらにはアンプルまたはアエロゾルボンベに
入れて提供する。The compositions of the invention can be provided in any form used in cosmetology. For example, creams or gels in bottles or tubes, emulsions or lotions in glass or plastic vials, or vials with a liquid meter, i.e. a vial with a device that allows you to count the number of droplets. , or even provided in ampoules or aerosol cylinders.
本発明は、皮膚用のクリーム、ゲル、乳剤、皮膚用のパ
ン状のバック、ローションの形態であることを特徴とす
る化粧用または皮膚用組成物に関するものであり、特に
、補薬が顔面と首に塗布するのに適した組成物に関する
。The present invention relates to a cosmetic or dermatological composition characterized in that it is in the form of a skin cream, gel, emulsion, skin bag or lotion, and in particular, the present invention relates to a cosmetic or skin composition characterized in that it is in the form of a skin cream, gel, emulsion, skin bread-like bag, or lotion. Concerning compositions suitable for application to the neck.
実際、組成物の形態に合わせて適当な補薬が用いられる
。補薬は、通常要求されるあらゆる性質を備えていなく
てはならない。この補薬は、皮膚に対する親和性が大き
く、完全な耐性があり安定で、使用しやすく気持ちよい
固さを有する必要がある。In fact, appropriate adjuvants are used depending on the form of the composition. The supplement must have all the properties normally required. This supplement must have a high affinity for the skin, be completely tolerated and stable, and have a consistency that is easy to use and pleasant.
使用可能な補薬としては、例えば、ステアリン酸グリセ
ロール、プロピレングリコーノペパルミテートやステア
レートの誘導体、ラノリン、グリセリン、セチルアルコ
ール、ポリアルコールや、一般に使用されている動物性
脂肪、無機物、蝋、界面活性剤、増粘剤、安定化剤、乳
化剤が挙げられる。Possible adjuvants include, for example, glycerol stearate, propylene glyconopepalmitate and stearate derivatives, lanolin, glycerin, cetyl alcohol, polyalcohols, commonly used animal fats, inorganic substances, waxes, Examples include surfactants, thickeners, stabilizers, and emulsifiers.
美容術で用いられる上記の様々な形態にするにはこの分
野で通常利用されている方法を用いることができる。Methods commonly used in this field can be used to form the above-mentioned various forms used in cosmetology.
本発明の成分A)とB)は、油相または水相の対する親
和性を考慮して、皮膚に対して有効な上記の補薬ならび
に物質の中に添加することができる。Components A) and B) of the invention can be incorporated into the abovementioned adjuvants and substances effective for the skin, taking into account their affinity for the oily or aqueous phase.
一般に、成分B)は乳化の開始と同時に混入する。Generally, component B) is incorporated at the same time as the start of emulsification.
成分A)は、乳化を終えた後に35℃以下の温度でのみ
添加する。Component A) is only added after emulsification has finished and at a temperature below 35°C.
実施例
以下の実施例は本発明の単なる例であって、本発明がこ
れら実施例に限定されることはない。EXAMPLES The following examples are merely examples of the present invention, and the present invention is not limited to these examples.
実施例1
流動ゲル
中和したカルボキシビニルポリマー
0.25〜0.65 g
カルボキシメチルセルロースナトリウム塩0.02〜0
.5g
プロピレングリコール 1〜5gポリグリセリ
ルメタクリレートのゲル
5〜10 g
ベルヒドロスクアレン 1〜5gγ−オリザノ
ール 0.05〜2gα−ビスアポロール
0.05〜1gスキナベンジャー(登録商
標) 1〜5g高分子量のペプチド 1〜5
gヒアルロン酸 0゜(11〜0.
05 g保存剤 十分な量
香料 十分な量着色料
十分な量精製水
全体が100gになるまで実施例2
0/W型流動エマルジヨン
ステアリン酸 0.5〜2.5gプロ
ピレングリコールの脂肪酸 1〜5gペルヒドロスクア
レン 1〜5gシアバターまたはココアバター
1〜5g
動物から得られたポリペプチド 0.1〜1g分技状脂
肪酸エステル 2〜12 gUVA/UV
B用フィルタ 0.5〜1.5gα−ビスアポロー
ル 0.05〜1g植物油
1〜5gγ−オリザノール 0.
05〜0.5gスキナベンジャー(登録商標) 1〜5
gヒアルロン酸 0.(11〜0.
05 g中和したカルボキシメチルセルロー
ス0.1〜1g
プロピレングリコール 3〜12 g尿素
0.5〜5g保存剤
十分な量香料
十分な量精製水 全体が10
0gになるまで実施例3
0/W型クリーム
乳化剤
−P、0.[E、脂肪酸エステル
−P、0.B、糖質 2〜7g−リン脂質
シリコーン油 0.5〜5g植物性1
0.2〜1gベルヒドロスクア
レン 1〜5′gUVA/UVB用フィルタ
0.5〜1.5gセチルアルコール
0.2〜1g植物油 1〜5g
植物ステロール 1〜2.5gγ−オリ
ザノール 0.05〜0.5gトリエタノ
ールアミン 0.3〜2g動物から得られた蛋
白質 1〜5gスキナベンジャー(登録商標)
1−〜5gヒアルロン酸 0.(11
〜0.05g中和したカルボキシビニルポリマ
ー0.3〜0.8g
尿素 0.5〜5g保存剤
十分な量香料
十分な量精製水 全体が
100gになるまで実施例4
W10型クリーム
グリセロールとソルビタンのインステアレート10 〜
12 g
ベルヒドロスクアレン 10 〜15 g2
−エチルへキシルスクシナート
10 〜15 g
アボガド油 3〜6g白蝋
3〜5gT−オリザノール
0.05〜0.5g微結晶性蝋
1〜3gスキナベンジャー(登録商標) 1〜5
gヒアルロン酸 0.(11〜0.
03 gグリセリン 2〜5g硫酸マ
グネシウム(MgSO,・7H20)0.7g
保存剤 十分な量香料
十分な量精製水
全体が100gになるまで実施例5
ディクリーム/顔面手入れ用クリーム
ソルビタンパルミテート 6.0g脂肪
酸のグリセリド 13.0 gワゞ
す′ ・ 4.0gオキ
シベンゼン 1.0gマツヨイ
グサ属植物の油 5.0gソルビトール
3.0g中和したカルボキシ
ビニルポリマー 0.5g牌膵臓織の抽出物
3.0gフラボフェロール(登録商標)
5.0 g保存剤
十分な量芳香性組成物
十分な量精製水 全体が100gにな
るまで実施例6
給温用ディクリーム
P、 0. B、セチルエーテル 3.
5gソルビタンステアレート 3.5g
脂肪酸のトリグリセリド 5gベルヒドロ
スクアレン 2g水素化ラノリン
5gマツヨイグサ属植物の油
5gUVA/UVB用紫外線遮蔽剤 2
gプロピレングリコール 5gフラボ
フェロール(登録商標)3g
ナトリウムピロリドンカルボキシレート2g中和したカ
ルボキシビニルポリマー 1g保存剤
十分電量芳香性組成物
十分な量精製水 全体が10
0 gになるまで実施例7
手入れ用クリーム
グリセロールとPEG100のステアレート6g
シアバター 5gマツヨイ
グサ属植物の油 5gセチルアルコール
2g脂肪酸のトリグリセリド
8gビタミンA
0.5 g生物からの抽出物
5gフラボフェロール(登録商41) 5
gグリセリン 5g中和した
カルボキシビニルポリマー 1g保存剤
十分な量芳香性組成物
十分な激情製水 全体が1
00gになるまで実施例8
顔面用ゲル
リポソームの形態のAGE 0.5
gフラボフェロール(登録商標)3g
ナトリウムピロリドンカルボキシレート2g保存剤
十分な量芳香性組成物
十分な量中和したカルボキシビニ
ルポリマー 1.5gプロピレングリコール
5g精製水 全体が100g
になるまで実施例9
日焼は防止用クリーム
ワセリン油 5gシリコー
ン油 1g脂肪酸エステル
5gラノリン誘導体
8gクリセロールとPEG100のステアレー
トgExample 1 Fluid gel Neutralized carboxyvinyl polymer 0.25-0.65 g Carboxymethyl cellulose sodium salt 0.02-0
.. 5 g Propylene glycol 1-5 g Polyglyceryl methacrylate gel 5-10 g Verhydrosqualene 1-5 g γ-Oryzanol 0.05-2 g α-Bisporol 0.05-1 g Skinavenger® 1-5 g High molecular weight peptides 1-5
g Hyaluronic acid 0° (11-0.
05 g Preservative Enough amount Flavoring Enough amount Coloring agent
Sufficient amount of purified water
Example 2 0/W type fluid emulsion Stearic acid 0.5-2.5 g Propylene glycol fatty acids 1-5 g Perhydrosqualene 1-5 g Shea butter or cocoa butter 1-5 g Obtained from animals Polypeptide 0.1-1g Technical fatty acid ester 2-12gUVA/UV
Filter for B 0.5-1.5g α-Bisporol 0.05-1g Vegetable oil
1-5gγ-oryzanol 0.
05-0.5g Skinavenger (registered trademark) 1-5
g Hyaluronic acid 0. (11~0.
05 g Neutralized carboxymethyl cellulose 0.1-1 g Propylene glycol 3-12 g Urea 0.5-5 g Preservative
enough fragrance
Sufficient amount of purified water Total 10
Example 3 0/W type cream emulsifier-P, 0. [E, fatty acid ester-P, 0. B. Carbohydrate 2-7g - Phospholipid silicone oil 0.5-5g Vegetable 1
0.2-1g Verhydrosqualene 1-5'g UVA/UVB filter
0.5-1.5g cetyl alcohol
0.2-1g vegetable oil 1-5g
Plant sterols 1-2.5g γ-oryzanol 0.05-0.5g Triethanolamine 0.3-2g Proteins obtained from animals 1-5g Skinavenger (registered trademark)
1-5g hyaluronic acid 0. (11
~0.05g Neutralized carboxyvinyl polymer 0.3-0.8g Urea 0.5-5g Preservative
enough fragrance
Sufficient amount of purified water Until the total amount is 100g Example 4 W10 type cream glycerol and sorbitan instearate 10 ~
12 g Verhydrosqualene 10-15 g2
-Ethylhexyl succinate 10-15 g Avocado oil 3-6 g White wax
3-5g T-oryzanol
0.05-0.5g microcrystalline wax
1-3g Skinavenger (registered trademark) 1-5
g Hyaluronic acid 0. (11~0.
03 g Glycerin 2-5 g Magnesium sulfate (MgSO, 7H20) 0.7 g Preservative Sufficient amount Fragrance
Sufficient amount of purified water
Until the total amount is 100 g Example 5 Di-cream/facial care cream Sorbitan palmitate 6.0 g Glyceride of fatty acid 13.0 g Wais' 4.0 g Oxybenzene 1.0 g Evening Primrose oil 5.0 g Sorbitol
3.0g neutralized carboxyvinyl polymer 0.5g pancreatic tissue extract
3.0g Flavopherol (registered trademark)
5.0 g preservative
Sufficient amount of aromatic composition
Sufficient amount of purified water until the total amount is 100g Example 6 Warming Day Cream P, 0. B, cetyl ether 3.
5g sorbitan stearate 3.5g
Triglycerides of fatty acids 5g Verhydrosqualene 2g Hydrogenated lanolin
5g evening primrose oil
5g UVA/UVB UV screening agent 2
g Propylene glycol 5 g Flavopherol® 3 g Sodium pyrrolidone carboxylate 2 g Neutralized carboxyvinyl polymer 1 g Preservative
Fully coulometric aromatic composition
Sufficient amount of purified water Total 10
Example 7 Care Cream Glycerol and PEG100 Stearate 6g Shea Butter 5g Evening Primrose Oil 5g Cetyl Alcohol
2g fatty acid triglyceride
8g vitamin A
0.5 g extract from an organism
5g Flavopherol (Registered Trademark 41) 5
g Glycerin 5g Neutralized carboxyvinyl polymer 1g Preservative
Sufficient amount of aromatic composition
Sufficient passionate water production total 1
Example 8 AGE in the form of facial gel liposomes 0.5
gFlavoferol (registered trademark) 3g Sodium pyrrolidone carboxylate 2g Preservative
Sufficient amount of aromatic composition
Sufficient amount of neutralized carboxyvinyl polymer 1.5g propylene glycol
5g purified water total 100g
Example 9 Sunburn prevention cream Vaseline oil 5g silicone oil 1g fatty acid ester
5g lanolin derivative
8g chrycerol and PEG100 stearate
Claims (15)
あって、主要成分として、 A)シリマリン(Silymarine)が豊富に含ま
れるオオアザミ(Silybum Marianum)
の果実の抽出物である「サンザシのアブソリュート(A
bsolu d′EpineBlanche)」と呼ば
れる物質と、 B)−遊離基の形態(1)、 −アルカリ金属塩またはアンモニウム塩の形態(2)、 −トリグリセリドの形態(3)、 −上記3つの形態(1)、(2)、(3) のうちの2つの混合物またはこれら3つの形態すべての
混合物の形態 のいずれかの形態に限られ、炭素原子を18〜22個含
む1種または複数の不可欠ポリ不飽和脂肪酸との混合物
を含むことを特徴とする組成物。(1) A cosmetic or dermatological composition for skin care, which contains as a main ingredient A) milk thistle (Silybum Marianum) rich in silymarine;
Hawthorn absolute (A
B) - Free radical form (1), - Alkali metal salt or ammonium salt form (2), - Triglyceride form (3), - The above three forms (1). ), (2), (3) or in the form of a mixture of all three of these forms, containing one or more essential polyols containing from 18 to 22 carbon atoms. A composition characterized in that it comprises a mixture with saturated fatty acids.
記不可欠ポリ不飽和脂肪酸(2)が、トリグリセリド(
3)の全部または一部の鹸化により得られることを特徴
とする請求項1に記載の組成物。(2) The essential polyunsaturated fatty acids (2) in the form of alkali metal or ammonium salts are triglycerides (
The composition according to claim 1, which is obtained by saponifying all or part of 3).
コーン油、ヒマワリ油、甘アーモンド油、マツヨイグサ
属植物の油、オニジシャ油、黒スグリの種子の油を含む
群の中から選択した植物油から得られることを特徴とす
る請求項1または2に記載の組成物。(3) The above essential fatty acids include wheat germ oil, olive oil,
3. The oil according to claim 1 or 2, characterized in that it is obtained from a vegetable oil selected from the group consisting of corn oil, sunflower oil, sweet almond oil, oil of evening primrose plants, oil of chinensis, and oil of black currant seeds. Composition.
(1)と、γ−リノレン酸を豊富に含む原料から得られ
た油(3)と、アルカリ金属塩またはアンモニウム塩の
形態のγ−リノレン酸(2)とからなる混合物であるこ
とを特徴とする請求項1〜3のいずれか1項に記載の組
成物。(4) Component B) comprises γ-linolenic acid (1) in the form of free radicals, an oil (3) obtained from a raw material rich in γ-linolenic acid, and the form of an alkali metal salt or ammonium salt. The composition according to any one of claims 1 to 3, characterized in that it is a mixture consisting of γ-linolenic acid (2).
記油が、マツヨイグサ属植物の油、オニジシャ油、黒ス
グリの種子の油と、シフォミケス類スピルリン目の菌(
champignons siphomycetes、
despirulines)、カエデの種子、またはホ
ップを抽出して得られる油を含む群の中から選択される
ことを特徴とする請求項4に記載の組成物。(5) The above-mentioned oil obtained from raw materials rich in γ-linolenic acid is mixed with oil of evening primrose plants, oil of evening primrose, oil of black currant seeds, and fungi of the order Siphomycetes and the order Spirulinae (
champions siphomycetes,
5. Composition according to claim 4, characterized in that it is selected from the group comprising oils obtained by extraction of hops, maple seeds or hops.
ることを特徴とする請求項1〜5のいずれか1項に記載
の組成物。(6) The composition according to any one of claims 1 to 5, wherein the component A) further contains a terpene of an essential oil.
ことを特徴とする請求項1〜6のいずれか1項に記載の
組成物。(7) The composition according to any one of claims 1 to 6, wherein the component A) further contains a flavonoid.
でいることを特徴とする請求項1〜7のいずれか1項に
記載の組成物。(8) The composition according to any one of claims 1 to 7, wherein the component A) further contains α-tocopherol.
%と、 −遊離基の形態、好ましくはγ−リノレン酸の形態の不
可欠脂肪酸(1)と、例えばトリグリセリド(3)の全
部または一部の鹸化により得ることのできるアルカリ金
属塩またはアンモニウム塩の形態の不可欠脂肪酸(2)
10〜25重量%とが含まれる混合物0.5〜10重量
%を含むことを特徴とする請求項1〜8のいずれか1項
に記載の組成物。(9) As main components: - 10-30% by weight of milk thistle extract; - 5-15% by weight of essential oil terpenes; - 5-15% by weight of flavonoids; - 5-20% by weight of α-tocopherol; - 25 to 40% by weight of the essential fatty acid triglyceride (3); - the essential fatty acid (1) in free radical form, preferably in the form of γ-linolenic acid, e.g. by saponification of all or part of the triglyceride (3); Essential fatty acids in the form of alkali metal or ammonium salts that can be obtained (2)
9. A composition according to any one of claims 1 to 8, characterized in that it comprises 0.5 to 10% by weight of a mixture comprising 10 to 25% by weight.
てルリジシャ油が含まれることを特徴とする請求項9に
記載の組成物。(10) The composition according to claim 9, characterized in that borage oil is contained as the essential fatty acid triglyceride (3).
上記不可欠脂肪酸(2)がマツヨイグサ属植物の油の鹸
化により得られることを特徴とする請求項10に記載の
組成物。(11) Composition according to claim 10, characterized in that said essential fatty acid (2) in the form of an alkali metal salt or an ammonium salt is obtained by saponification of the oil of a plant of the genus evening primrose.
酸(1)と、マツヨイグサ属植物の油(3)と、マツヨ
イグサ属植物の油(3)の鹸化により得られたγ−リノ
レン酸のアルカリ金属塩(2)とからなる混合物である
ことを特徴とする請求項1〜8のいずれか1項に記載の
組成物。(12) Component B) is γ-linolenic acid obtained by saponification of γ-linolenic acid (1) in the form of free radicals, evening primrose plant oil (3), and evening primrose plant oil (3). The composition according to any one of claims 1 to 8, characterized in that it is a mixture consisting of an alkali metal salt of an acid (2).
ポリエチレングリコール中に含まれたα−トコフェロー
ル0.05〜2重量%と の混合物1〜10重量%と が含まれる混合物を含むことを特徴とする請求項1〜8
と12のいずれか1項に記載の肌の手入れのための美容
用または皮膚用組成物。(13) Main ingredients: - 1 to 10% by weight of evening primrose oil; - 5% (dry extract) of milk thistle defatted fruit;
Claims 1 to 8 comprising a mixture containing 0.05 to 2% by weight of α-tocopherol contained in polyethylene glycol and 1 to 10% by weight.
and 12. The cosmetic or dermatological composition for skin care according to any one of Items 12 and 12.
ポリエチレングリコール中に含まれたα−トコフェロー
ル1重量%と の混合物5重量%と、 −UVA−UVB用紫外線遮蔽剤1〜10重量%と、 −脾臓の抽出物1〜10重量%と が含まれる混合物を含むことを特徴とする請求項1〜8
、12、13のいずれか1項に記載の組成物。(14) Main ingredients: - 5% by weight of evening primrose oil; - 5% (dry extract) of milk thistle defatted fruit;
5% by weight of a mixture with 1% by weight of α-tocopherol contained in polyethylene glycol; - 1-10% by weight of an ultraviolet screening agent for UVA-UVB; - 1-10% by weight of a spleen extract. Claims 1 to 8 comprising a mixture.
The composition according to any one of , 12 and 13.
形態であることを特徴とする請求項1〜14のいずれか
1項に記載の組成物。(15) The composition according to any one of claims 1 to 14, which is in the form of a cream, gel, emulsion, or lotion for the skin.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8700550 | 1987-01-19 | ||
FR8700550A FR2609630B1 (en) | 1987-01-19 | 1987-01-19 | NOVEL COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING AN EXTRACT OF SILYBUM MARIANUM FRUITS RICH IN SILYMARINE ASSOCIATED WITH ESSENTIAL FATTY ACIDS |
FR8705089 | 1987-04-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63239208A true JPS63239208A (en) | 1988-10-05 |
Family
ID=9347041
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63009436A Pending JPS63239208A (en) | 1987-01-19 | 1988-01-19 | Beauty or skin composition containing silymarine-rich extract of silybum marianum fruit and essential fatty acid |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS63239208A (en) |
FR (1) | FR2609630B1 (en) |
ZA (1) | ZA88222B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0495008A (en) * | 1990-08-10 | 1992-03-27 | Kanebo Ltd | Skin aging inhibitor and skin cosmetic containing the same |
WO1998056338A1 (en) * | 1997-06-10 | 1998-12-17 | Sunstar Inc. | Skin-lightening cosmetic |
JP2007507476A (en) * | 2003-10-06 | 2007-03-29 | ラボラトワール ド デルモ−コスメチック アニマル(エル.デー.セー.アー) エス アー エス | Pet Animal Skin Beauty Composition |
JP2016023170A (en) * | 2014-07-23 | 2016-02-08 | 小林製薬株式会社 | External composition |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196448A (en) * | 1991-01-22 | 1993-03-23 | Stiefel Laboratories, Inc. | Antiinflammatory compositions and method of use |
CA2119000A1 (en) * | 1993-03-19 | 1994-09-20 | David Frederick Horrobin | Formulation for use in smokers |
DE102005048780A1 (en) * | 2005-10-10 | 2007-04-12 | Beiersdorf Ag | Hydrous cosmetic preparation with dissolved flavonolignans |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2577421B2 (en) * | 1984-10-19 | 1990-01-05 | Courtin Olivier | COSMETIC FOR DELAYING AGING OF THE SKIN AND METHOD OF APPLICATION |
FR2594691B1 (en) * | 1986-02-24 | 1990-08-03 | Bonne Claude | NEW COSMETIC PREPARATIONS CONTAINING EXTRACT OF SILYBUM MARIANUM FRUITS |
-
1987
- 1987-01-19 FR FR8700550A patent/FR2609630B1/en not_active Expired - Fee Related
-
1988
- 1988-01-13 ZA ZA88222A patent/ZA88222B/en unknown
- 1988-01-19 JP JP63009436A patent/JPS63239208A/en active Pending
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0495008A (en) * | 1990-08-10 | 1992-03-27 | Kanebo Ltd | Skin aging inhibitor and skin cosmetic containing the same |
WO1998056338A1 (en) * | 1997-06-10 | 1998-12-17 | Sunstar Inc. | Skin-lightening cosmetic |
US6669932B2 (en) | 1997-06-10 | 2003-12-30 | Sunstar Inc. | Skin-whitening cosmetic |
JP2007507476A (en) * | 2003-10-06 | 2007-03-29 | ラボラトワール ド デルモ−コスメチック アニマル(エル.デー.セー.アー) エス アー エス | Pet Animal Skin Beauty Composition |
JP2016023170A (en) * | 2014-07-23 | 2016-02-08 | 小林製薬株式会社 | External composition |
Also Published As
Publication number | Publication date |
---|---|
FR2609630B1 (en) | 1991-01-04 |
ZA88222B (en) | 1988-09-28 |
FR2609630A1 (en) | 1988-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4997649A (en) | Cosmetic and dermatological compositions including an extract of Silybum marianum rich in silymarine associated with essential fatty acids | |
EP1002526B1 (en) | Skin whitening composition containing bearberry extract and a reducing agent | |
JPH0940523A (en) | Fibroblast proliferation promoter containing water extract form chlorella | |
JP7275103B2 (en) | Novel cosmetic use of Nephelium lapaceum extract | |
JP4104180B2 (en) | Lipase activity promoter | |
JP3563089B2 (en) | External preparation for skin | |
KR100892888B1 (en) | Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof | |
GB2181349A (en) | Skin care composition containing polyunsaturated fatty acids | |
ES2311730T3 (en) | USE OF ISOFLAVONES TO FAVOR SLIMMING. | |
KR102142311B1 (en) | Skin external composition comprising tangeretin | |
JP2897973B2 (en) | Cosmetic or dermatological composition | |
JP2008260721A (en) | External preparation for skin | |
JP2009073777A (en) | Cosmetic | |
CA2461462A1 (en) | Cosmetic composition for human skin and hair care | |
JPH09227353A (en) | Skin whitening cosmetic composition | |
JPS63239208A (en) | Beauty or skin composition containing silymarine-rich extract of silybum marianum fruit and essential fatty acid | |
JP2572730B2 (en) | Skin cosmetics | |
EP0613368A1 (en) | Skin regenerating cosmetic composition. | |
US5976515A (en) | Blood flow amount-improving agent comprising steroid derivative and cosmetic using same | |
KR20030065095A (en) | Compositions of anti-ageing cosmetics containing Molokhia extracts | |
RU2205627C1 (en) | Toxin-removal face cream | |
JP4754834B2 (en) | Cosmetics | |
RU2069557C1 (en) | Cream for skin | |
RO107545B1 (en) | Cream for oily skin | |
RU2212229C1 (en) | Diurnal recovering cream |